Zusammenfassung
➲ Das Magenkarzinom stellt trotz weltweit abnehmender Inzidenz weiterhin eine der häufigsten malignombedingten Todesursachen dar.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adachi Y, Kitano S (2001) Surgery for gastric cancer: 10-year experience worldwide. Gastric Cancer 4:166–174
Bonekamp JJ, Hermans J, Sasako M, van deVelde CJH (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908–914
Cuschieri A, Weeden S, Fielding J et al. (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC-randomized surgical trial. Br J Cancer 79:1522–1530
Dent DM, Madden MV, Price SK (1988) Randomized comparison of R1-and R2-gastrectomy for gastric carcinoma. Br J Surg 75:110–112
Furukawa H, Hiratsuka M, Ishikawa O et al. (2000) Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method. Ann Surg 7:669–673
Gotoda T, Yanagisawa A, Sasako M et al. (2000) Incidence of lymph node metastasis from early gastric cancer:estimation with a large number of cases at two large centers. Gastric Cancer 3:219–225
Hanazaki K, Sodeyama H, Mochizuki Y et al. (1999) Efficacy of extended lymphadenectomy in the noncurative gastrectomy for advanced gastric cancer. Hepatogatroenterology 46:2677–2682
Hermanek P (1996) Differenziertes chirurgisches Vorgehen bei der kurativen Therapie des Magenkarzinoms. Leber Magen Darm 26: 64–72
Hiller WFA, Jähne J, Meyer HJ (1997) Impact of D2 lymphadenectomy on morbidity and long-term survival in patients with gastric cancer. Onkologie 20:145–150
Hirasuka M, Miyashiro I, Ishikawa O et al. (2001) Application of sentinel node biopsy to gastric cancer surgery. Surgery 129:335–340
Jähne J (2002) Lymphadenektomie. Zentralbl Chir 127:550–553
Jaehne J, Meyer HJ, Maschek H, Bruns E, Pichlmayr R (1992) Lymphadenectomy in gastric carcinoma-a prospective and prognostic study. Arch Surg 127:290–294
Japanese classification of gastric carcinoma-2nd Engl edn (1998) Japanese Gastric Cancer Association. Gastric Cancer 1:10–24
Kell MR, Winter DC, O’Sullivon GC, Shanahan F, Redmond HP (2000) Biological behaviour and clinical implications of micrometastases. Br J Surg 87:1629–1639
Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M (2002) Radio-guided sentinel node detection for gastric cancer. Br J Surg 89: 604–608
Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H (1999) Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Langenbeck’s Arch Surg 384:149–157
Meyer HJ, Jähne J (1994) Rationale and technique of systematic lymph node dissection in gastric carcinoma. Dig Surg 11:72–77
Meyer HJ, Jähne J (1999) Lymph node dissection for gastric cancer. Semin Surg Oncol 17:117–124
Meyer HJ, Jähne J, Wilke H (1993) Perspectives of surgery and multi-modality treatment in gastric carcinoma. J Cancer Res Clin Oncol 119:384–394
Meyer HJ, Zachert HR, Jähne J (2000) Magenkarzinom: Stellenwert der Lymphknotendissektion. Visceralchirurgie 35:257–264
Miwa K, Miyazaki I, Sahara H et al. (1995) Rationale for extensive lymphadenectomy in early gastric carcinoma. Br J Cancer 72:1518–1523
Mönig SP, Collet PH, Baldus SE et al. (2001) Splenectomy in proximal gastric cancer: Frequency of lymph node metastasis to the splenic hilus. J Surg Oncol 76:89–92
Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5
Natsugoe S, Nakashima S, Matsumoto M et al. (1999) Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma. Gastric Cancer 2:179–185
Noguchi Y, Yamamoto Y, Morinaga S et al. (2002) Does pancreaticosplenectomy contribute to better survical? Hepatogastroenterology 49:1436–1440
Robertson CS, Chung SCS, Woods SDS et al. (1994) A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220:176–182
Roder JD, Böttcher K, Siewert JR, Busch R, Meyer HJ (1993) Prognostic factors in gastric carcinoma. Cancer 72:2089–2097
Sasako M (1997) Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 84:1567–1571
Sasako M (2000) What is reasonable treatment for gastric adenocarcinoma? J Gastroenterol 35:116–120
Sendler A, Etter M, Böttcher K, Siewert JR (2002) Resektionsausmaß in der Chirurgie des Magenkarzinoms. Chirurg 73:316–324
Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer-ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461
Siewert JR, Kestlmeier R, Busch R et al. (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN 0 and pN 1 lymph node metastases. Br J Surg 83:1144–1147
Siewert JR, Sendler A (2000) Potential and futility of sentinel node detection for gastric cancer. Recent Results Cancer Res 157:259–269
van de Velde CJH (2002a) Is there any need for D2-lymphadenectomy? Results of European studies on D2-lymphadenectomy in gastric cancer. Tumori 2:47–49
van de Velde CJH (2002b): (Persönliche Mitteilungen)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Meyer, H.J. (2004). Lymphadenektomie. In: Management des Magen- und Ösophaguskarzinoms. Onkologie aktuell. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18700-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-18700-1_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62254-0
Online ISBN: 978-3-642-18700-1
eBook Packages: Springer Book Archive